Safety Considerations Common Side Effects Nausea, vomiting, diarrhea, decreased appetite, constipation, and abdominal pain Injection site reactions (redness, itching, swelling) Hypoglycemia (especially if used with insulin or sulfonylureas) Serious Risks Pancreatitis: Seek immediate medical attention for severe abdominal pain
Patients can track their usage through the Lilly Health app , which offers progress visualization ability and personalized information about their treatment plans
Product Specifications Purity : 99% (HPLC verified) Form : Lyophilized powder in a 5mL sterile vial Unit Size : 60mg per vial Storage : Store at -20C or below, protected from light Usage : For in vitro laboratory research only
Collectively, these modifications prolong the half-life of semaglutide to approximately 1 week, or 165 hours (Lau et al., 2015)
Key Takeaways Retatrutide is being studied as a triple agonist that targets GIP, GLP-1, and glucagon receptors
Common questions about tirzepatide
.webp)
